GAITHERSBURG, Md., Feb. 28, 2018 /PRNewswire/ — Viela Bio announced today that it has incorporated as an independent inflammation- and autoimmunity-focused biotechnology company after spinning out six molecules from MedImmune, the global biologics research and development arm of…










